Back to top

SPRY Maintained by Leerink Partners -- Price Target Lowered to $24.00

SPRY Maintained by Leerink Partners -- Price Target Lowered to $24.00

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

ARS Pharmaceuticals, Inc. (SPRY)